TY - JOUR T1 - DEtection of colon cancer metastases with fluorescence laparoscopy in orthotopic nude mouse models AU - Menen RS, Kaushal S, Snyder CS, Talamini MA, Hoffman RM, Bouvet M Y1 - 2012/09/01 N1 - 10.1001/archsurg.2012.704 JO - Archives of Surgery SP - 876 EP - 880 VL - 147 IS - 9 N2 - Objective  To improve detection of colon cancer metastases using fluorescence laparoscopy (FL).Design  An orthotopic mouse model of human colon cancer was established by intracecal injection of HCT-116 human colon cancer cells expressing green fluorescent protein into 12 mice. One group modeled early disease and the second modeled late metastatic disease. For the early-disease model, 2 weeks after implantation, 6 mice underwent 2 modalities of laparoscopy: bright field laparoscopy (BL) and FL. The number of metastases identified within each of the 4 abdominal quadrants was recorded with both laparoscopy modalities. This process was repeated in the late-metastatic disease group 4 weeks after implantation. All animals were then humanely sacrificed and imaged using open fluorescence laparoscopy (OL) as a positive control to identify metastases.Setting  Basic science laboratory.Participants  Twelve female, 6-week-old nude mice.Interventions  Detection of tumor foci by FL compared with BL.Main Outcome Measures  Number of tumors identified in each quadrant.Results  Fluorescence laparoscopy enabled superior visualization of colon cancer metastases compared with BL in the early (P = .03) and late (P = .002) models of colon cancer. Compared with OL, BL was significantly inferior in the early (P = .04) and late (P < .001) groups. Fluorescence laparoscopy was not significantly different from OL in the early (P = .85) or late (P = .46) group. Thus, FL allowed identification of micrometastases that could not be distinguished from surrounding tissue using BL.Conclusions  The use of FL enables identification of metastases that could not be visualized using standard laparoscopy. This report illustrates the important clinical potential for FL in the surgical treatment of cancer. SN - 0004-0010 M3 - doi: 10.1001/archsurg.2012.704 UR - http://dx.doi.org/10.1001/archsurg.2012.704 ER -